Cite
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease.
MLA
Hansson, Oskar, et al. “The Alzheimer’s Association Appropriate Use Recommendations for Blood Biomarkers in Alzheimer’s Disease.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, vol. 18, no. 12, Dec. 2022, pp. 2669–86. EBSCOhost, https://doi.org/10.1002/alz.12756.
APA
Hansson, O., Edelmayer, R. M., Boxer, A. L., Carrillo, M. C., Mielke, M. M., Rabinovici, G. D., Salloway, S., Sperling, R., Zetterberg, H., & Teunissen, C. E. (2022). The Alzheimer’s Association appropriate use recommendations for blood biomarkers in Alzheimer’s disease. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 18(12), 2669–2686. https://doi.org/10.1002/alz.12756
Chicago
Hansson, Oskar, Rebecca M. Edelmayer, Adam L. Boxer, Maria C. Carrillo, Michelle M. Mielke, Gil D. Rabinovici, Stephen Salloway, Reisa Sperling, Henrik Zetterberg, and Charlotte E. Teunissen. 2022. “The Alzheimer’s Association Appropriate Use Recommendations for Blood Biomarkers in Alzheimer’s Disease.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 18 (12): 2669–86. doi:10.1002/alz.12756.